DE60118742D1 - Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel - Google Patents

Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel

Info

Publication number
DE60118742D1
DE60118742D1 DE60118742T DE60118742T DE60118742D1 DE 60118742 D1 DE60118742 D1 DE 60118742D1 DE 60118742 T DE60118742 T DE 60118742T DE 60118742 T DE60118742 T DE 60118742T DE 60118742 D1 DE60118742 D1 DE 60118742D1
Authority
DE
Germany
Prior art keywords
medicaments
duty
dispersion system
drug dispersion
water heavy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118742T
Other languages
English (en)
Inventor
Esteban Chornet
Claudia Ishizawa
Severian Dumitriu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemestrie Inc
Original Assignee
Kemestrie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemestrie Inc filed Critical Kemestrie Inc
Application granted granted Critical
Publication of DE60118742D1 publication Critical patent/DE60118742D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Colloid Chemistry (AREA)
DE60118742T 2000-07-07 2001-07-06 Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel Expired - Lifetime DE60118742D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21662700P 2000-07-07 2000-07-07
US25238900P 2000-11-21 2000-11-21
PCT/CA2001/000993 WO2002003962A2 (en) 2000-07-07 2001-07-06 Drug delivery system for poorly water soluble drugs

Publications (1)

Publication Number Publication Date
DE60118742D1 true DE60118742D1 (de) 2006-05-24

Family

ID=26911183

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118742T Expired - Lifetime DE60118742D1 (de) 2000-07-07 2001-07-06 Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel

Country Status (12)

Country Link
US (1) US20030157171A1 (de)
EP (1) EP1299089B1 (de)
JP (1) JP2004502722A (de)
AT (1) ATE322891T1 (de)
AU (1) AU2001272262A1 (de)
BR (1) BR0112258A (de)
CA (1) CA2415081A1 (de)
DE (1) DE60118742D1 (de)
IL (1) IL153814A0 (de)
NO (1) NO20030073L (de)
NZ (1) NZ523418A (de)
WO (1) WO2002003962A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050221501A1 (en) * 2003-12-24 2005-10-06 Arnot Kate I Dissolution method
IL160095A0 (en) * 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
CA2604078C (en) * 2005-04-08 2013-07-23 Abbott Laboratories Enteric pharmaceutical formulations of choline salt of fenofibric acid
WO2007036044A1 (en) * 2005-09-28 2007-04-05 Dnp Canada Inc. Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia
WO2007056205A2 (en) * 2005-11-04 2007-05-18 Eastman Chemical Company Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
BRPI0710578B1 (pt) 2006-04-05 2016-11-29 Woodland Biofuels Inc método de produção de etanol a partir de gás de síntese
US20100129423A1 (en) * 2007-04-19 2010-05-27 Medovent Gmbh Device made at least partially of n-acetylchitosan with controlled biodissolution
CA2810842C (en) * 2010-09-09 2018-06-26 Micell Technologies, Inc. Macrolide dosage forms
CA2844008A1 (en) 2011-08-01 2013-02-07 Ranbaxy Laboratories Limited Dissolution enhanced controlled drug delivery system for poorly water soluble drugs
CN103315960A (zh) * 2012-03-19 2013-09-25 胡容峰 基于球晶技术固体自微乳及其制备方法
US20200262937A1 (en) * 2017-09-27 2020-08-20 Association For The Advancement Of Tissue Engineering Cell Based Technologies & Therapies (A4Tec)- High molecular weight chitosan, process for obtaining and uses thereof
KR102407470B1 (ko) * 2021-08-09 2022-06-10 인제대학교 산학협력단 하이드로겔에 담지된 약물의 방출량 검출 방법
CN114515268A (zh) * 2022-02-21 2022-05-20 上海宣泰医药科技股份有限公司 熊去氧胆酸药物组合物及其制备方法和药物制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620706A (en) * 1995-04-10 1997-04-15 Universite De Sherbrooke Polyionic insoluble hydrogels comprising xanthan and chitosan
CA2243619A1 (fr) * 1998-07-17 2000-01-17 Universite De Sherbrooke Hydrogels polyioniques a base de xanthane et chitosane pour stabilisation et relargage controle des vitamines

Also Published As

Publication number Publication date
NZ523418A (en) 2004-09-24
CA2415081A1 (en) 2002-01-17
ATE322891T1 (de) 2006-04-15
EP1299089B1 (de) 2006-04-12
WO2002003962A2 (en) 2002-01-17
JP2004502722A (ja) 2004-01-29
IL153814A0 (en) 2003-07-31
BR0112258A (pt) 2003-06-24
WO2002003962A3 (en) 2002-06-13
US20030157171A1 (en) 2003-08-21
NO20030073D0 (no) 2003-01-07
EP1299089A2 (de) 2003-04-09
NO20030073L (no) 2003-03-06
AU2001272262A1 (en) 2002-01-21

Similar Documents

Publication Publication Date Title
DE60118742D1 (de) Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel
FR16C0030I1 (fr) Glycoproteine d'hyaluronidase soluble (shasegp), son procede de preparation, utilisations et compositions pharmaceutiques le comportant
HK1070063A1 (en) Stable polymorph of flibanserin, technical processfor its preparation and the use thereof for prepa ring medicaments
PT1214093E (pt) Processo para a preparacao de um produto comprimido a base de isomaltulose, isomaltose e variantes da isomaltose e produtos respectivos
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
IS7286A (is) Aðferðir til þess að mæla hæfi glatiramerasetats
HK1084941A1 (en) Compounds and their use
YU91002A (sh) Derivati acilfenil-karbamida, postupak za njihovu proizvodnju i njihova primena kao leka
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
WO2004050057A3 (en) An exopolysaccharides delivery system for active molecules
HUP0300163A2 (hu) Hialuronsav-származékokból kialakított klatrát komplexek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EP1067911A4 (de) Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben.
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
DE69924004D1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
IL150528A0 (en) Ibuprofen containing active agent preparation
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
CY1111960T1 (el) Νεα φαρμακευτικα παρασκευασματα καθως επισης μεθοδος για την παρασκευη αυτων
CA2407795A1 (en) Fluorescein isothiocyanate (fitc) sinistrin, its production and use
AU7599900A (en) Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles
AU2003232481A1 (en) Ferrocenyl ligands and method for the production of such ligands
CO5261508A1 (es) Compuestos bi-basicos como inhibidores de triptasa, procedimiento para su preparacion y su utilizacion como medicamentos
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
AU2001252825A1 (en) Thieno(2,3-d)pyrimidinediones and their use as pharmaceuticals
AU667294B2 (en) Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals

Legal Events

Date Code Title Description
8332 No legal effect for de